Uncoupling protein 2 (UCP2), a mitochondrial anion carrier ubiquitously expressed in many cell types to reduce oxidative stress, has been proposed as a therapeutic factor for modifying the progression of PD pathogenesis since its expression has been shown to attenuate rotenone-induced mitochondrial fragmentation [209]. The gene discussed is UCP2; the disease is Parkinson disease.